Objective Therapeutic exercise is already used to ameliorate some of the side effects of
cancer treatment. Recent studies examined its preventive potential regarding treatment …

Physical activity is known to prevent the occurrence of cancer and decrease the risk of
breast cancer. At diagnosis of breast cancer, fewer than half of the patients reach the …

Asymptomatic cardiotoxicity following breast cancer treatment is a significant issue for many
patients, as these patients typically face an increased risk of cardiovascular disease (CVD) …

Background Adjuvant systemic breast cancer treatment improves disease specific outcomes,
but also presents with cardiac toxicity. In this post-hoc exploratory analysis of the OptiTrain …

Background: Current anticancer treatments for breast cancer (BC) may cause cardiotoxicity.
This study aimed to investigate the effectiveness of aerobic exercise in mitigating …

Advances in breast cancer treatment have improved disease-free survival and overall
survival in women with early-stage breast cancer. However, these improvements may be …

Purpose In rodents, a single exercise bout performed 24 h prior to a single doxorubicin
treatment provides cardio-protection. This study investigated whether performing this …

Background Anthracyclines and monoclonal antibodies against human epidermal growth
factor receptor-2 (HER2) are frequently used to treat breast cancer but they are associated …

Background Breast cancer (BC) treatment with anthracyclines and/or anti-human epidermal
growth factor receptor-2 (HER2) antibodies is associated with an increased risk of …

Objective Animal data suggest that exercise during chemotherapy is cardioprotective, but
clinical evidence to support this is limited. This study evaluated the effect of exercise during …